Liaoning and Anhui provinces have had 29 indigenous infections in four days. Officials have not yet found a “patient zero” who caused the local transmission. In addition, a newly developed adenovirus neo-crown vaccine has been administered in Shanghai, and only one dose is required.
There has been a recent resurgence of local cases of NCC pneumonia in China. There have been 29 cases of infection in Liaoning and Anhui in 4 days, including 13 in Yingkou, Liaoning and 2 in Shenyang; 12 in Liuan, Anhui and 2 in Hefei. on May 15, Wu Zunyou, chief epidemiologist at the Chinese CDC, said in an interview with Punch News that the outbreak spread earlier in Yingkou, Liaoning than in Liuan, Anhui, and that the specific source of the virus is to be investigated.
Ms. Guan, a resident of Shenyang, told Radio Free Asia that local government officials are so nervous about the recent sudden appearance of indigenous cases that they fear being removed from their posts by higher authorities.
“There have been more than 30 cases nationwide, nine new cases in Yingkou, and then 12 cases in Anhui, all of which are indigenous cases. Previously, they all came back from abroad with imported cases. It is possible that the epidemic has re-emerged. Even yesterday and today, hundreds of confirmed cases occurred in Taiwan.”
On May 13, a confirmed case was found in Lu’an, Anhui Province, after routine nucleic acid testing of a patient who visited the hospital. In the following two days, confirmed cases were found in Anhui and Liaoning. In contrast, no local cases were found in China in the previous 22 days.
Chief epidemiologist Wu Zunyou said that although the first confirmed case of the local outbreak came from Liu’an, Anhui, the source of the outbreak most likely started in Yingkou, Liaoning.
Authorities can’t cut the chain of transmission if they can’t find the source
Sun Decai, who works at a hospital in Anhui province, told the station that it is difficult to cut off the recent chain of transmission because the authorities cannot find the “zero-sense patient” for the new wave of local cases. He said.
“Right now there is just no number zero, no number zero case has been found. According to the sporadic infections that have occurred around the world, they are infecting others, and it is not known whether the virus they are carrying is the raw material virus or the latest, just them (CDC). So, there are a lot of questions about this. Where is patient zero? Do officials need to do crowd control.”
From Monday (17) to Wednesday, Anhui’s Lu’an required full nucleic acid testing in the main city and key areas, while Anhui and Liaoning provincial governments urged residents to get vaccinated against the new coronavirus as soon as possible. On Monday, all those entering Yingkou, Liaoning Province, must have a negative nucleic acid test certificate within seven days.
In addition to this, Song Liangwei, deputy secretary of the party group of Liaoning Provincial Health Committee, Jin Li, deputy mayor of Yingkou Municipal Government, Wang Cheng, head of the Municipal Health Committee, a number of district governments were admonished for talking and warned.
China launches new vaccine but still no data provided
In addition, the Shanghai CDC announced this Sunday that the recombinant new crown vaccine with adenovirus vector, developed in collaboration with the team of academician Chen Wei of the Institute of Biological Engineering of the Military Medical Research Institute of the Academy of Military Sciences, has been launched in all districts of Shanghai, with only one dose of vaccination required for the whole process.
Shanghai medical insider Song Li said in an interview with this station that previously there was only no live vaccine in China, no adenovirus vaccine, and recently there will be another transgenic vaccine will also come out.
“The best transgenic vaccine in China is Mrna vaccine. Not long ago Gao Fu (director of the CDC) did not say that the effectiveness of domestic vaccines is not too good. In fact, he was trying to help endorse a vaccine. It’s this vaccine that’s not on the market yet.”
China has officially announced that more than 400 million people have been vaccinated, and since May 13, the “Adenovirus vector recombinant New Crown vaccine” has been available in all districts of Shanghai. The vaccine was the first in the world to start clinical studies on March 16, 2020, and was approved by the Drug Administration for conditional marketing in China on February 25 this year.
The Shanghai CDC also revealed that the adenovirus vector vaccine produced by Concierto is completely different in terms of technical principles and vaccination procedures compared to the three inactivated vaccines previously used in Shanghai, but it is the same in terms of vaccination method, age range and safety.
Recent Comments